tiprankstipranks
Trending News
More News >
Amneal Pharmaceuticals Inc (AMRX)
NASDAQ:AMRX
US Market

Amneal Pharmaceuticals (AMRX) Income Statement

Compare
600 Followers

Amneal Pharmaceuticals Income Statement

Last quarter (Q4 2025), Amneal Pharmaceuticals's total revenue was $814.32M, an increase of 11.47% from the same quarter last year. In Q4, Amneal Pharmaceuticals's net income was $35.08M. See Amneal Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 3.02B$ 2.79B$ 2.39B$ 2.21B$ 2.09B
Gross Profit
$ 1.14B$ 1.02B$ 863.87M$ 791.46M$ 768.97M
Operating Expenses
$ 713.00M$ 771.11M$ 659.50M$ 886.39M$ 616.26M
Depreciation and Amortization
$ 223.57M$ 236.19M$ 229.40M$ 240.18M$ 233.41M
EBITDA
$ 603.87M$ 439.77M$ 500.78M$ 440.21M$ 401.10M
Operating Income
$ 423.09M$ 249.33M$ 204.37M$ -94.93M$ 152.72M
Other Income/Expenses
$ -283.88M$ -304.34M$ -244.64M$ -153.20M$ -121.35M
Pretax Income
$ 139.21M$ -55.01M$ -40.27M$ -248.13M$ 31.37M
Net Income
$ 72.06M$ -116.89M$ -83.99M$ -129.99M$ 10.62M
Per Share Metrics
Basic EPS
$ 0.23$ -0.38$ -0.48$ -0.86$ 0.07
Diluted EPS
$ 0.22$ -0.38$ -0.48$ -0.86$ 0.07
Weighted Average Shares Outstanding
313.37M 308.98M 174.99M 150.94M 148.92M
Weighted Average Shares Outstanding (Diluted)
324.81M 308.98M 176.14M 150.94M 151.82M
Currency in USD

Amneal Pharmaceuticals Earnings and Revenue History